Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지

Behavioral Sensitization and M1 Muscarinic Acetylcholine Receptor mRNA Expression in Methamphetamine-Administered Mice

  • Kim, Kyung-In (Department of Pharmacology, College of Pharmacy, Sungkyunkwan Univeristy) ;
  • Cho, Jae-Han (Department of Pharmacology, College of Pharmacy, Sungkyunkwan Univeristy) ;
  • Park, Hyun-Jung (Department of Pharmacology, College of Pharmacy, Sungkyunkwan Univeristy) ;
  • Lee, Seok-Yong (Department of Pharmacology, College of Pharmacy, Sungkyunkwan Univeristy) ;
  • Jang, Choon-Gon (Department of Pharmacology, College of Pharmacy, Sungkyunkwan Univeristy)
  • Published : 2004.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Repeated administration of psychostimulants such as amphetamines increases locomotor activity in rodents. These drugs, including methamphetamine, enhance dopaminergic neurotransmission and result in hyper-locomotion and behavioral sensitization. It is well known that the existence of a complex balance between the cholinergic and dopaminergic systems in the central nervous system. Thus, behavioral sensitization by methamphetamine may be related to the expression of the M1 muscarinic acetylcholine receptors gene. The present study investigated the changes of M1R mRNA in hyperlocomotor activity and behavioral sensitization by methamphetamine (2 mg/kg) in mice. Our results showed that M1R mRNA expression was increased in the frontal cortex and the hippocampus region (the CA2 region) in the acute methamphetamine administered group compared to the saline administered group. In the chronic group, M1R mRNA expression was increased in the frontal cortex ill1d the hippocampus regions (CA2 and DG regions) in melt1amphetamine administered group compared to saline control group. These results indicate that acute or chronic treatment of mathamphetamine leads to the region-specific changes in mRNA expression levels of M1R. Therefore, Therefore, the present result suggests that M1R may play a role in modulating of methamphetamine-induced behavioral sensitization in mice.

Keywords

References

  1. Bonner T. I., Buckley N. J., Young A. C. and Brann M. R. (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science. 237, 527-532 https://doi.org/10.1126/science.3037705
  2. Buchanan R. W., Kirkpatrick B., Heinrichs D. W. and Carpenter W. T. (1990) Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry. 147, 290-294
  3. Buckley N. J., Bonner T. I. and Brann M. R (1988) Localization of a family of muscarinic receptor mRNA in rat brain. J Neurosci. 8, 4646-4652
  4. Buckley N. J., Bonner T. I., Buckley C. M. and Brann M. R. (1989) Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-Kl cells. Mol Phannacol. 35, 469-476.
  5. Bymaster F. P, Shannon H. E., Rasmussen K., DeLapp N. W., Ward J. S., Calligaro D.O., Mitch C. H., Whitesitt C., Ludvigsen T. S., Sheardown M., Swedberg M., Rasmussen T., Olesen P. H., Jeppesen L., Sauerberg P. and Fink-Jensen A. (1999) Potential role of muscarinic receptors in schizophrenia. Life Sci. 64, 527-534 https://doi.org/10.1016/S0024-3205(98)00597-9
  6. Caulfield M. P (1993) Muscarinic receptors-characterization, coupling and function. Pharmacol Ther. 58, 319-379 https://doi.org/10.1016/0163-7258(93)90027-B
  7. Caulfield M. P. and Birdsall N. J. (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Phannacol Rev. 50(2), 279-290
  8. Di Chiara G., Morelli M. and Consolo S. (1994) Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/ NMDA interactions. Trends Neurosci. 17, 228-233 https://doi.org/10.1016/0166-2236(94)90005-1
  9. D$\ddot{o}$rje F., Wess J., Lambrecht G., Tacke R., Mutschler E. and Brann M. (1991) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmacol Exp Ther. 256, 727-733
  10. Fleckenstein A. E., Gibb J. W. and Hanson G. R. (2000) Differential effects of stimulants on monoaminergic transporters:pharmacological conse-quences and implications for neurotoxicity. Eur J. Phannacol. 406, 1-13 https://doi.org/10.1016/S0014-2999(00)00639-7
  11. Fornari R V., Moreira K. M. and Oliveira M. G. (2000) Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory. Learn Mem. 7(5), 287-292 https://doi.org/10.1101/lm.34900
  12. Gerber D. J., Sotnikova T. D., Gainetdinov R. R., Huang S. Y., Caron M. G. and Tonegawa S. (2001) Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci U.S.A 98(26),15312-15317 https://doi.org/10.1073/pnas.261583798
  13. Goto Y. and O'Donnell P. (2001) Network synchrony in the nucleus accumbens in vivo. J. Neuroici. 21, 4498-4504
  14. Graybiel A. M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13, 244-253 https://doi.org/10.1016/0166-2236(90)90104-I
  15. Kalivas P. W., Sorg B. A. and Hooks M. S. (1993) The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol. 4, 315-334
  16. Kitanaka J., Kitanaka N. and Takemura M. (2003) Chronic methamphetamine administration reduces histamine-stimulated phosphoinositide hydrolysis in mouse frontal cortex. Biochem Biophys Res Commun. 300(4), 932-937 https://doi.org/10.1016/S0006-291X(02)02948-0
  17. Kitayama S. and Dohi T. (1996) Cellular and molecular aspects of monoamine neurotransmitter transporters. Jpn J. Pharmacol. 72, 195-208
  18. Lee E. H. and Tsai M. J. (1989) The hippocampus and amygdala mediate the locomotor stimulating effects of corticotropinreleasing factor in mice. Behav Neural BioI. 51(3), 412-423 https://doi.org/10.1016/S0163-1047(89)91052-2
  19. Levey A. I., Kitt C. A., Simonds W. F., Price D. L. and Brann M. R. (1991) Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J. Neurosci. 11, 3218-3226
  20. Maeda A., Kubo T., Mishina M. and Numa S. (1988) Tissue distribution of mRNA encoding muscarinic acetylcholine receptor subtypes. FEBS Lett. 239, 339-342. https://doi.org/10.1016/0014-5793(88)80947-5
  21. Mark G. P., Hajnal A., Kinney A. E. and Keys A. S. (1999) Selfadministration of cocaine increases the release of acetylcholine to a greater extent than response-independent cocaine in the nucleus accumbens of rats. Psychophannacology (Berl). 143(1), 47-53 https://doi.org/10.1007/s002130050918
  22. Nathanson N. M. (1987) Molecular properties of the muscarinic acetylcholine receptor. Annu Rev Neurosci. 10, 195-236 https://doi.org/10.1146/annurev.ne.10.030187.001211
  23. Nestby P., Vanderschuren L. J., De Vries T. J., Hogenboom F., Wardeh G., Mulder A. H. and Schoffelmeer A. N. (1997) Ethanol, like psychostimulants and morphine, causes long-lasting hyperreactivity of dopamine and acetylcholine neurons of rat nucleus accumbens: possible role in behavioural sensitization. Psychophannacology (Bert). 133(1),69-76 https://doi.org/10.1007/s002130050373
  24. Peralta E. G., Ashkenazi A., Winslow J. A. W, Smith D. H., Ramachandran J. and Capon D. J. (1987) Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J. 6, 3923-3929
  25. Piazza P. V., Deminiere J. M., Ie Moal M. and Simon H. (1990) Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine selfadministration. Brain Res. 514(1),22-6 https://doi.org/10.1016/0006-8993(90)90431-A
  26. Post R. M. and Weiss S. R. B. (1988) Sensitization and kindling: implications for the evolution of psychiatric symptomatology. In: Kalivas, P. W., Barnes, C. D. (Eds.), Sensitization in the Nervous System. Telford Press, Caldwell, 257-292
  27. Robinson T. E. and Becker J. B. (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration; A review and evaluation of animal models of amphetamine psychosis. Brain Res Rev. 11, 157-198 https://doi.org/10.1016/0165-0173(86)90002-0
  28. Robinson T. E. and Berridge K. C. (1993) The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Rev. 18, 247-291 https://doi.org/10.1016/0165-0173(93)90013-P
  29. Robinson T. E., Browman K. E., Crombag H. S. and Badiani A. (1998) Modulation of the induction or expression of psychostimulant sensitization by the circumstances surrounding drug administration. Neurosci Biobehav Rev. 22, 347-354 https://doi.org/10.1016/S0149-7634(97)00020-1
  30. Seiden L. S., Sabol K. E. and Ricaurte G. A. (1993) Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol. 32, 639-677
  31. Sousa F. C., Gomes P. B., Noronha E. C., Macedo D. S., Vasconcelos S. M., Fonteles M. M. and Viana G. S. (2001) Effects of dopaminergic and cholinergic interactions on rat behavior. Life Sci. 69(20), 2419-2428 https://doi.org/10.1016/S0024-3205(01)01315-7
  32. Uhl G., Lin Z., Metzger T. and Dar D. E. (1998) Dopamine transporter mutants, small molecules, and approaches to cocaine antagonist/dopamine transporter disinhibitor development. In : Amara SG,editor. Methods in enzymology. Academic Press 296, 456-465 https://doi.org/10.1016/S0076-6879(98)96033-5
  33. Vilaro M. T., Palacios J. M. and Mengod G. (1994) Multiplicity of muscarinic autoreceptor subtypes? Comparison of the distribution of cholinergic cells and cells containing mRNA for five subtypes of muscarinic receptors in the rat brain. Mol. Brain Res. 21, 30-46 https://doi.org/10.1016/0169-328X(94)90375-1
  34. Wang H., Lipfert L., Malbon C. C. and Bahouth S. (1989) Sitedirected anti-peptide antibodies define the topography of the beta-adrenergic receptor. J Biol Chem. 264, 14424-14431
  35. Wess J. (1996) Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol. 10, 69-99 https://doi.org/10.1615/CritRevNeurobiol.v10.i1.40
  36. Wise R. A. (1996) Addictive drugs and brain stimulation reward. Annu Rev Neurosci. 19, 319-340 https://doi.org/10.1146/annurev.ne.19.030196.001535
  37. Wolf M. E., Dahlin S. L., Hu X. T., Xue C. J. and White K. (1995) Effects of lesions of prefrontal cortex, amygdale, or fornix on behavioral sensitization to amphetamine: Comparison with N-methy1-D-aspartate antagonists. Neurosci. 69,417-439 https://doi.org/10.1016/0306-4522(95)00248-H
  38. Wortley K. E., Hughes Z. A., Heal D. J. and Stanford S. C. (1999) Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d-amphetamine: modulation by a2-adrenoceptors. Br J Pharm. 127, 1860-1866 https://doi.org/10.1038/sj.bjp.0702720
  39. Yui K. and Miura T. (1996) Behavioral responses induced by repeated treatment with methamphetamine alone and in combination with scopolamine in rats. Neuropsychobiology. 33(1), 21-7 https://doi.org/10.1159/000119244